These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17956293)

  • 1. Interleukin-1 and inflammatory neurodegeneration.
    Simi A; Tsakiri N; Wang P; Rothwell NJ
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1122-6. PubMed ID: 17956293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 1 in the brain: biology, pathology and therapeutic target.
    Rothwell NJ; Luheshi GN
    Trends Neurosci; 2000 Dec; 23(12):618-25. PubMed ID: 11137152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic modelling of interleukin-1 receptor antagonist in plasma and cerebrospinal fluid of patients following subarachnoid haemorrhage.
    Gueorguieva I; Clark SR; McMahon CJ; Scarth S; Rothwell NJ; Tyrrell PJ; Hopkins SJ; Rowland M
    Br J Clin Pharmacol; 2008 Mar; 65(3):317-25. PubMed ID: 17875190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential.
    Rothwell N
    Brain Behav Immun; 2003 Jun; 17(3):152-7. PubMed ID: 12706413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interleukin-1 system: an attractive and viable therapeutic target in neurodegenerative disease.
    Allan SM; Pinteaux E
    Curr Drug Targets CNS Neurol Disord; 2003 Oct; 2(5):293-302. PubMed ID: 14529361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of pro- and antiinflammatory cytokines in neurodegeneration.
    Allan SM
    Ann N Y Acad Sci; 2000; 917():84-93. PubMed ID: 11268414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connection between inflammatory processes and transmittor function-Modulatory effects of interleukin-1.
    Spulber S; Schultzberg M
    Prog Neurobiol; 2010 Feb; 90(2):256-62. PubMed ID: 19853010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CNS injury: the role of the cytokine IL-1.
    Gibson RM; Rothwell NJ; Le Feuvre RA
    Vet J; 2004 Nov; 168(3):230-7. PubMed ID: 15501140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1: a master regulator of neuroinflammation.
    Basu A; Krady JK; Levison SW
    J Neurosci Res; 2004 Oct; 78(2):151-6. PubMed ID: 15378607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1/IL-1ra balance in the brain revisited - evidence from transgenic mouse models.
    Spulber S; Bartfai T; Schultzberg M
    Brain Behav Immun; 2009 Jul; 23(5):573-9. PubMed ID: 19258032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of interleukin-1 and lipocortin-1 in ischaemic brain damage.
    Rothwell NJ; Relton JK
    Cerebrovasc Brain Metab Rev; 1993; 5(3):178-98. PubMed ID: 8217499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional role of proinflammatory and anti-inflammatory cytokines in seizures.
    Vezzani A; Moneta D; Richichi C; Perego C; De Simoni MG
    Adv Exp Med Biol; 2004; 548():123-33. PubMed ID: 15250591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 and stroke: biomarker, harbinger of damage, and therapeutic target.
    Denes A; Pinteaux E; Rothwell NJ; Allan SM
    Cerebrovasc Dis; 2011; 32(6):517-27. PubMed ID: 22104408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 and neuronal injury.
    Allan SM; Tyrrell PJ; Rothwell NJ
    Nat Rev Immunol; 2005 Aug; 5(8):629-40. PubMed ID: 16034365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Regulatory Role of IL-10 in Neurodegenerative Diseases.
    Porro C; Cianciulli A; Panaro MA
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32659950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pragmatic target discovery from novel gene to functionally defined drug target: the interleukin-1 story.
    Allan SM
    Methods Mol Med; 2005; 104():333-46. PubMed ID: 15454676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) study.
    Galea J; Ogungbenro K; Hulme S; Patel H; Scarth S; Hoadley M; Illingworth K; McMahon CJ; Tzerakis N; King AT; Vail A; Hopkins SJ; Rothwell N; Tyrrell P
    J Neurosurg; 2018 Feb; 128(2):515-523. PubMed ID: 28298024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1alpha induces angiogenesis in brain endothelial cells in vitro: implications for brain angiogenesis after acute injury.
    Salmeron K; Aihara T; Redondo-Castro E; Pinteaux E; Bix G
    J Neurochem; 2016 Feb; 136(3):573-80. PubMed ID: 26546397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute IL-1RA treatment suppresses the peripheral and central inflammatory response to spinal cord injury.
    Yates AG; Jogia T; Gillespie ER; Couch Y; Ruitenberg MJ; Anthony DC
    J Neuroinflammation; 2021 Jan; 18(1):15. PubMed ID: 33407641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.